Fed Minutes Reveal Potential Rate Hikes if Inflation Persists Amid Geopolitical Tensions Microns Monthly Surge Echoes 1987 Rally Analysts Flag Potential Value Opportunity London Stock Exchange Group Income Growth Driven by Tradeweb Performance TIC Solutions Sees Price Target Upgrade Following Mixed FirstQuarter Performance PDD Holdings Revenue Growth Potential Amid Regulatory Resolution According to Morgan Stanley International Graduates Face Growing Hurdles in Securing US Employment Hiring Slowdown and Immigration Shifts Challenge American Dream OWLT Q1 2026 Earnings EPS Beat Surprises Market Amidst Operational Progress SNTI Q1 2026 Earnings EPS Beat Surprise as Biotech Advances Pipeline ACIC Q1 2026 Earnings EPS Misses Estimates Stock Declines VKTX Q1 2026 Earnings WiderthanExpected Loss in a PreRevenue Stage SMXT Q1 2026 Earnings Narrow Loss Highlights Cost Management Focus aka Brands Holding Corp AKA Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uptick First Mid Bancshares FMBH Holds Steady Near Support Amid Consolidation Tenaya Therapeutics TNYA Slips 228 as Stock Tests Key Support at 073 Big Tree Cloud Holdings DSY Tumbles 735 as Support Levels Approach Freightos CRGO Slips 073 Testing Support Amid Freight Sector Headwinds Telos Corporation TLS Experiences Minor Decline Maintains Position Above Key Support AI Industry Emerges as Key Beneficiary in MuskAltman Trial Suggesting Increased Sector Transparency LPL Financial Q1 2026 Earnings Earnings Slightly Ahead of Estimates Shares Edge Lower Prelude Therapeutics PRLD Climbs 3 as Bullish Momentum Builds Above Key Support YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data ORKA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Hayward Holdings Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed VSNT Q1 2026 Earnings EPS Surges Past Estimates with 949 Beat SIMO Q1 2026 Earnings EPS Surges Past Estimates Stock Climbs on Strong Beat IonQ Q1 2026 Earnings EPS Beat Highlights Progress in Quantum Commercialization Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues